Clinical trial
Study to Improve the Treatment of Epilepsy (SITE)
NCT00133081 · UMC Utrecht, Other · Unknown status
Key facts
| NCT number | NCT00133081 |
|---|---|
| Title | Study to Improve the Treatment of Epilepsy (SITE) |
| Official title | Study to Improve the Treatment of Epilepsy (SITE). A Randomized Study Comparing Adjustment of Treatment to Reduce Side Effects of Antiepileptic Drugs With Continuing Treatment Unchanged |
| Lead sponsor | UMC Utrecht, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Epilepsy |
| Intervention type | Drug |
| Interventions | All registered antiepileptic drugs |
| Enrollment | 255 |
| Start date | Oct 1, 2002 |
| Completion | Aug 1, 2006 |
| First posted | Aug 22, 2005 |
| Last update posted | Oct 21, 2005 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: